Search
Now showing items 1-3 of 3
Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety
(
Taylor and Francis Ltd
, 2020 , Article Review)
The COVID-19 pandemic is caused by the severe acute-respiratory-syndrome-coronavirus-2 that uses ACE2 as its receptor. Drugs that raise serum/tissue ACE2 levels include ACE inhibitors (ACEIs) and angiotensin-II receptor ...
SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort
(
Springer Nature
, 2021 , Article)
Euglycemic diabetic ketoacidosis (EuDKA) secondary to Sodium-glucose co-transporter-2 inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but increasingly reported phenomenon. Not much is known about the burden ...
Diabetes-induced peripheral neuropathy: Is prescribing physical exercise the answer?
(
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
, 2024 , Other)
Diabetes mellitus, a chronic metabolic disorder characterized by hyperglycemia, has become a global health concern with an increasing prevalence worldwide. The International Diabetes Federation (IDF) estimates that over ...